Literature DB >> 11023529

De novo factor VIII gene intron 22 inversion in a female carrier presents as a somatic mosaicism.

J Oldenburg1, S Rost, O El-Maarri, M Leuer, K Olek, C R Müller, R Schwaab.   

Abstract

The intron 22 inversion represents the most prevalent factor VIII gene defect in severe hemophilia A, accounting for about 40% of all mutations. It is hypothesized that the inversion mutations occur almost exclusively in germ cells during meiotic cell division by intrachromosomal recombination between 1 of 2 telomeric copies of the Int22h region and its intragenic homologue. The majority of inversion mutations originate in male germ cells, where the lack of bivalent formation may facilitate flipping of the telomeric end of the single X chromosome. This is the first intron 22 inversion that presents as a somatic mosaicism in a female, affecting only about 50% of lymphocyte and fibroblast cells of the proposita. Supposing a post-zygotic de novo mutation as the usual cause of somatic mosaicism, the finding would imply that the intron 22 inversion mutation is not restricted to meiotic cell divisions but can also occur during mitotic cell divisions, either in germ cell precursors or in somatic cells. (Blood. 2000;96:2905-2906)

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11023529

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  9 in total

1.  Mosaicism in men in hemophilia: is it exceptional? Impact on genetic counselling.

Authors:  C Costa; A M Frances; S Letourneau; E Girodon-Boulandet; M Goossens
Journal:  J Thromb Haemost       Date:  2008-12-01       Impact factor: 5.824

2.  Somatic mosaicism in hemophilia A: a fairly common event.

Authors:  M Leuer; J Oldenburg; J M Lavergne; M Ludwig; A Fregin; A Eigel; R Ljung; A Goodeve; I Peake; K Olek
Journal:  Am J Hum Genet       Date:  2001-06-14       Impact factor: 11.025

3.  Survival of male patients with incontinentia pigmenti carrying a lethal mutation can be explained by somatic mosaicism or Klinefelter syndrome.

Authors:  S Kenwrick; H Woffendin; T Jakins; S G Shuttleworth; E Mayer; L Greenhalgh; J Whittaker; S Rugolotto; T Bardaro; T Esposito; M D'Urso; F Soli; A Turco; A Smahi; D Hamel-Teillac; S Lyonnet; J P Bonnefont; A Munnich; S Aradhya; C D Kashork; L G Shaffer; D L Nelson; M Levy; R A Lewis
Journal:  Am J Hum Genet       Date:  2001-10-22       Impact factor: 11.025

4.  Detection of mosaics in hemophilia A by deep Ion Torrent sequencing and droplet digital PCR.

Authors:  Eric Manderstedt; Rosanna Nilsson; Rolf Ljung; Christina Lind-Halldén; Jan Astermark; Christer Halldén
Journal:  Res Pract Thromb Haemost       Date:  2020-09-07

Review 5.  Haemophilia.

Authors:  Erik Berntorp; Kathelijn Fischer; Daniel P Hart; Maria Elisa Mancuso; David Stephensen; Amy D Shapiro; Victor Blanchette
Journal:  Nat Rev Dis Primers       Date:  2021-06-24       Impact factor: 52.329

6.  Direct duplication 12p11.21-p13.31 mediated by segmental duplications: a new recurrent rearrangement?

Authors:  Manuela De Gregori; Tiziano Pramparo; Luigi Memo; Giorgio Gimelli; Jole Messa; Mariano Rocchi; Maria Grazia Patricelli; Roberto Ciccone; Roberto Giorda; Orsetta Zuffardi
Journal:  Hum Genet       Date:  2005-11-15       Impact factor: 4.132

7.  Women with Hemophilia: Case Series of Reproductive Choices and Review of Literature.

Authors:  Shadan Lalezari; Assaf A Barg; Rima Dardik; Jacob Luboshitz; Dalia Bashari; Einat Avishai; Gili Kenet
Journal:  TH Open       Date:  2021-06-01

Review 8.  Eighteen years of molecular genotyping the hemophilia inversion hotspot: from southern blot to inverse shifting-PCR.

Authors:  Liliana C Rossetti; Claudia P Radic; Miguel M Abelleyro; Irene B Larripa; Carlos D De Brasi
Journal:  Int J Mol Sci       Date:  2011-10-24       Impact factor: 5.923

9.  Identification of the Intron 22 and Intron 1 Inversions of the Factor VIII Gene in Iraqi Kurdish Patients With Hemophilia A.

Authors:  Aveen M Raouf Abdulqader; Ali Ibrahim Mohammed; Shwan Rachid; Peyman Ghoraishizadeh; Sarwar Noori Mahmood
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.